Previous studies have also shown that AKT1 mutations are found in ~1% of all cancers, and the most prevalent mutant AKT1(E17K) leads to its localization to the plasma membrane, invoking a consistent activation of AKT signaling in cancer cells [13,14]. Here, AKT1 is linked to cancer.